Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation and Evaluation of an HIV-2 Viral Load and ARV Resistance Informed Algorithm for 2nd-line ART in HIV-2 Infected Patients in the Initiative Sénégalaise d'Accès Aux Antirétroviraux (ISAARV) Program

NCT03394196 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03394196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03394196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation and Evaluation of an HIV-2 Viral Load and ARV Resistance Informed Algorithm for 2nd-line ART in HIV-2 Infected Patients in the Initiative Sénégalaise d'Accès Aux Antirétroviraux (ISAARV) Program
Lead sponsor
University of Washington
Phase
Not applicable
Overall status
Terminated
Start date
July 4, 2018
Completion date
May 31, 2020
Enrollment
152 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-2 infection